Coherent (COHR) announced a breakthrough in short-reach optical interconnect technology with the demonstration of its next-generation 2D VCSEL and ...

Inherited metabolic diseases are rare monogenic conditions that disrupt biochemical pathways, affecting energy production and ...

Unfortunately, satellite signals are weak and a strong interference signal can create a GNSS denial region. The solution ...

The FDA approved imlunestrant for treatment of certain adults with breast cancer who experience disease progression after at least one prior line of endocrine therapy.